The sepsis diagnostics market in the UK is expected to reach a projected revenue of US$ 106.2 million by 2033. A compound annual growth rate of 8.5% is expected of the UK sepsis diagnostics market from 2026 to 2033.
The UK sepsis diagnostics market generated a revenue of USD 55.5 million in 2025 and is expected to reach USD 106.2 million by 2033.
The UK market is expected to grow at a CAGR of 8.5% from 2026 to 2033.
In terms of segment, conventional diagnostics was the largest revenue generating method in 2025.
Automated Diagnostics is the most lucrative method segment registering the fastest growth during the forecast period.
Sepsis diagnostics market data book summary
Market revenue in 2025
USD 55.5 million
Market revenue in 2033
USD 106.2 million
Growth rate
8.5% (CAGR from 2026 to 2033)
Largest segment
Conventional diagnostics
Fastest growing segment
Automated Diagnostics
Historical data
2021 - 2024
Base year
2025
Forecast period
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Automated Diagnostics, Conventional Diagnostics
Key market players worldwide
BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress
Other key industry trends
In terms of revenue, UK accounted for 4.5% of the global sepsis diagnostics market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Europe, Germany sepsis diagnostics market is projected to lead the regional market in terms of revenue in 2033.
UK is the fastest growing regional market in Europe and is projected to reach USD 106.2 million by 2033.
According to the UK Sepsis Trust, sepsis claims a life every three seconds worldwide. In the UK alone, approximately 245,000 people are affected by sepsis each year, with around 48,000 succumbing to sepsis-related illnesses annually.
This figure exceeds the combined death rates of breast, bowel, and prostate cancers. On a global scale, sepsis is responsible for about 11 million deaths annually. Despite its severity, early diagnosis can make sepsis highly treatable in many cases.
The UK Sepsis Trust (UKST) is dedicated to combating this life-threatening condition by preventing avoidable deaths and providing support for those impacted by sepsis. The Trust works to improve awareness, advance early diagnosis, and enhance treatment protocols.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Sepsis Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Conventional Diagnostics was the largest segment with a revenue share of 62.34% in 2025.
Horizon Databook has segmented the U.K. sepsis diagnostics market based on automated diagnostics, conventional diagnostics covering the revenue growth of each sub-segment from 2021 to 2033.
According to the UK Sepsis Trust, sepsis claims a life every three seconds worldwide. In the UK alone, approximately 245,000 people are affected by sepsis each year, with around 48,000 succumbing to sepsis-related illnesses annually.
This figure exceeds the combined death rates of breast, bowel, and prostate cancers. On a global scale, sepsis is responsible for about 11 million deaths annually. Despite its severity, early diagnosis can make sepsis highly treatable in many cases.
The UK Sepsis Trust (UKST) is dedicated to combating this life-threatening condition by preventing avoidable deaths and providing support for those impacted by sepsis. The Trust works to improve awareness, advance early diagnosis, and enhance treatment protocols.
U.K. Sepsis Diagnostics Market Method Outlook (Revenue, USD Million , 2021-2033)
Automated Diagnostics
Conventional Diagnostics
U.K. Sepsis Diagnostics Market Technology Outlook (Revenue, USD Million , 2021-2033)
Immunoassays
Others
Microbiology
Flow Cytometry
Molecular Diagnostics
U.K. Sepsis Diagnostics Market Pathogen Outlook (Revenue, USD Million , 2021-2033)
Bacterial Sepsis
Fungal Sepsis
Viral Sepsis and Others
U.K. Sepsis Diagnostics Market Testing Type Outlook (Revenue, USD Million , 2021-2033)
Laboratory Testing
Point-of-Care Testing
U.K. Sepsis Diagnostics Market End User Outlook (Revenue, USD Million , 2021-2033)
Hospitals & Clinics
Pathology & Reference Laboratories
Research Institutes and Others
U.K. Sepsis Diagnostics Market Product Outlook (Revenue, USD Million , 2021-2033)
Instruments
Blood Culture Media
Assay Kits & Reagents
Software
Reasons to subscribe to Sepsis Diagnostics Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Sepsis Diagnostics Market Outlook databook
Our clientele includes a mix of Sepsis Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.K. Sepsis Diagnostics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.K. Sepsis Diagnostics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.